These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 35123528)

  • 1. Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.
    Lukkarinen H; Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Hiltunen M; Rauramaa T; Nägga K; Leinonen V; Tullberg M
    Fluids Barriers CNS; 2022 Feb; 19(1):11. PubMed ID: 35123528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus.
    Grønning R; Jeppsson A; Hellström P; Laurell K; Farahmand D; Zetterberg H; Blennow K; Wikkelsø C; Tullberg M
    Fluids Barriers CNS; 2023 Oct; 20(1):77. PubMed ID: 37880775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
    Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
    PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
    Jeppsson A; Wikkelsö C; Blennow K; Zetterberg H; Constantinescu R; Remes AM; Herukka SK; Rauramaa T; Nagga K; Leinonen V; Tullberg M
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1117-1123. PubMed ID: 31167811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.
    Braun M; Bjurnemark C; Seo W; Freyhult E; Nyholm D; Niemelä V; Blennow K; Zetterberg H; Fällmar D; Kultima K; Virhammar J
    Fluids Barriers CNS; 2022 Feb; 19(1):15. PubMed ID: 35164790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus.
    Nakajima M; Miyajima M; Ogino I; Akiba C; Kawamura K; Kamohara C; Fusegi K; Harada Y; Hara T; Sugano H; Tange Y; Karagiozov K; Kasuga K; Ikeuchi T; Tokuda T; Arai H
    J Alzheimers Dis; 2018; 66(1):319-331. PubMed ID: 30248058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus.
    Jeppsson A; Höltta M; Zetterberg H; Blennow K; Wikkelsø C; Tullberg M
    Fluids Barriers CNS; 2016 Jul; 13(1):13. PubMed ID: 27472944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain tissue Aβ42 levels are linked to shunt response in idiopathic normal pressure hydrocephalus.
    Abu Hamdeh S; Virhammar J; Sehlin D; Alafuzoff I; Cesarini KG; Marklund N
    J Neurosurg; 2019 Jan; 130(1):121-129. PubMed ID: 29350601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic normal-pressure hydrocephalus: pathophysiology and diagnosis by CSF biomarkers.
    Jeppsson A; Zetterberg H; Blennow K; Wikkelsø C
    Neurology; 2013 Apr; 80(15):1385-92. PubMed ID: 23486875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Vanninen A; Tesseur I; Pemberton D; Van Der Ark P; Kokkola T; Herukka SK; Rauramaa T; Hiltunen M; Blennow K; Zetterberg H; Leinonen V
    J Alzheimers Dis; 2023; 91(1):305-319. PubMed ID: 36404546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
    Manniche C; Simonsen AH; Hasselbalch SG; Andreasson U; Zetterberg H; Blennow K; Høgh P; Juhler M; Hejl AM
    J Alzheimers Dis; 2020; 75(3):937-947. PubMed ID: 32390628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
    Abu-Rumeileh S; Giannini G; Polischi B; Albini-Riccioli L; Milletti D; Oppi F; Stanzani-Maserati M; Capellari S; Mantovani P; Palandri G; Cortelli P; Cevoli S; Parchi P
    J Alzheimers Dis; 2019; 68(2):723-733. PubMed ID: 30883350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
    J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    Yang F; Yang L; Fang X; Deng Y; Mao R; Yan A; Wei W
    J Alzheimers Dis; 2023; 93(4):1341-1354. PubMed ID: 37182875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study.
    Kanemoto H; Mori E; Tanaka T; Suehiro T; Yoshiyama K; Suzuki Y; Kakeda K; Wada T; Hosomi K; Kishima H; Kazui H; Hashimoto M; Ikeda M
    Int Psychogeriatr; 2023 Sep; 35(9):509-517. PubMed ID: 34399871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
    Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
    J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative biomarkers in patients with idiopathic normal pressure hydrocephalus showing a favorable shunt surgery outcome.
    Hong YJ; Kim MJ; Jeong E; Kim JE; Hwang J; Lee JI; Lee JH; Na DL
    J Neurol Sci; 2018 Apr; 387():21-26. PubMed ID: 29571865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus.
    Miyajima M; Nakajima M; Ogino I; Miyata H; Motoi Y; Arai H
    Eur J Neurol; 2013 Feb; 20(2):236-42. PubMed ID: 22672777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.